Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Neutron therapy and increased late complication rates.

Abratt RP.

Radiother Oncol. 2014 Feb;110(2):375. doi: 10.1016/j.radonc.2013.12.016. Epub 2014 Feb 20. No abstract available.

PMID:
24560752
[PubMed - in process]
2.

The consumer-provider relationship in the dental industry.

Griffith AS, Abratt R.

Health Mark Q. 2013;30(3):221-34. doi: 10.1080/07359683.2013.814492. Review.

PMID:
23924221
[PubMed - indexed for MEDLINE]
3.

Cancer care in South Africa.

Abratt RP, Dreosti L, Ruff P.

Lancet Oncol. 2012 Aug;13(8):e324. doi: 10.1016/S1470-2045(12)70284-X. No abstract available.

PMID:
22846830
[PubMed - indexed for MEDLINE]
4.

Treatment of carcinoma of the anal canal at Groote Schuur Hospital.

Robertson B, Shepherd L, Abratt RP, Hunter A, Goldberg P.

S Afr Med J. 2012 May 23;102(6):559-61.

PMID:
22668963
[PubMed - indexed for MEDLINE]
5.

Neutron radiotherapy in South Africa: neutron radiotherapy: society comments.

Fourie S, Abratt R, Botha M, De Muellenaere R, Gouws L, Hart G, Jordaan A, Szpak W.

S Afr Med J. 2012 Mar 23;102(5):271. No abstract available.

PMID:
22554323
[PubMed - indexed for MEDLINE]
6.

The fast neutron therapy programme for patients in South Africa should come to an end.

Abratt RP.

S Afr Med J. 2012 Jan 25;102(2):58. No abstract available.

PMID:
22310428
[PubMed - indexed for MEDLINE]
7.

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group, Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK.

J Clin Oncol. 2011 Jun 1;29(16):2171-7. doi: 10.1200/JCO.2010.32.3139. Epub 2011 Apr 18.

PMID:
21502557
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial.

de Boer RH, Arrieta Ó, Yang CH, Gottfried M, Chan V, Raats J, de Marinis F, Abratt RP, Wolf J, Blackhall FH, Langmuir P, Milenkova T, Read J, Vansteenkiste JF.

J Clin Oncol. 2011 Mar 10;29(8):1067-74. doi: 10.1200/JCO.2010.29.5717. Epub 2011 Jan 31.

PMID:
21282537
[PubMed - indexed for MEDLINE]
9.

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).

Le Péchoux C, Laplanche A, Faivre-Finn C, Ciuleanu T, Wanders R, Lerouge D, Keus R, Hatton M, Videtic GM, Senan S, Wolfson A, Jones R, Arriagada R, Quoix E, Dunant A; Prophylactic Cranial Irradiation (PCI) Collaborative Group.

Ann Oncol. 2011 May;22(5):1154-63. doi: 10.1093/annonc/mdq576. Epub 2010 Dec 7.

PMID:
21139020
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Accreditation of training courses in good clinical practice.

Abratt RP, Hunter AJ.

S Afr Med J. 2010 Nov 9;100(11):4529. No abstract available.

PMID:
21081031
[PubMed - in process]
11.

How has the OSD affected our state hospitals?

Parkes J, Abratt R, Taylor A, le Feuvre D, Murray E, Robertson B, Kotze T, Marais D, Khan D, Kilborn T, Wieselthaler N, Gajjar H, Handler L, Fagan J, Spitaels A, Morrison A, Davidson A, Salie S, Urban M, Rajkumar A, Pretorius V, van Niekerk M, Ferreira G, Wolmerans M, Cyster L, King D, Okwuosa S, van Staden S, van Niekerk M, Winckler J, Meissenheimer H, Botes A, Tait D, Visagie J, Swarts S, Klocke M, Lomas V, Marais I, Vijoen W, Perry J, Nkosi N, Stuve K.

S Afr Med J. 2009 Nov;99(11):788-9. No abstract available.

PMID:
20218474
[PubMed - indexed for MEDLINE]
12.

A randomized, double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer.

Horti J, Widmark A, Stenzl A, Federico MH, Abratt RP, Sanders N, Pover GM, Bodrogi I.

Cancer Biother Radiopharm. 2009 Apr;24(2):175-80. doi: 10.1089/cbr.2008.0588.

PMID:
19409038
[PubMed - indexed for MEDLINE]
13.

Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.

Le Péchoux C, Dunant A, Senan S, Wolfson A, Quoix E, Faivre-Finn C, Ciuleanu T, Arriagada R, Jones R, Wanders R, Lerouge D, Laplanche A; Prophylactic Cranial Irradiation (PCI) Collaborative Group.

Lancet Oncol. 2009 May;10(5):467-74. doi: 10.1016/S1470-2045(09)70101-9. Epub 2009 Apr 20.

PMID:
19386548
[PubMed - indexed for MEDLINE]
14.

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer.

Tan EH, Rolski J, Grodzki T, Schneider CP, Gatzemeier U, Zatloukal P, Aitini E, Carteni G, Riska H, Tsai YH, Abratt R.

Ann Oncol. 2009 Jul;20(7):1249-56. doi: 10.1093/annonc/mdn774. Epub 2009 Mar 10.

PMID:
19276396
[PubMed - indexed for MEDLINE]
Free Article
15.

Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.

Reck M, Macha HN, Del Barco S, Cornes P, Vaissière N, Morand M, Riggi M, Abratt R.

Lung Cancer. 2009 Jun;64(3):319-25. doi: 10.1016/j.lungcan.2008.10.014. Epub 2008 Dec 17.

PMID:
19095327
[PubMed - indexed for MEDLINE]
16.

Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial.

Eisen T, Oudard S, Szczylik C, Gravis G, Heinzer H, Middleton R, Cihon F, Anderson S, Shah S, Bukowski R, Escudier B; TARGET Study Group.

J Natl Cancer Inst. 2008 Oct 15;100(20):1454-63. doi: 10.1093/jnci/djn319. Epub 2008 Oct 7.

PMID:
18840822
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Part II: Cancer in Indigenous Africans--causes and control.

Sitas F, Parkin DM, Chirenje M, Stein L, Abratt R, Wabinga H.

Lancet Oncol. 2008 Aug;9(8):786-95. doi: 10.1016/S1470-2045(08)70198-0. Review.

PMID:
18672214
[PubMed - indexed for MEDLINE]
18.

Part I: Cancer in Indigenous Africans--burden, distribution, and trends.

Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H.

Lancet Oncol. 2008 Jul;9(7):683-92. doi: 10.1016/S1470-2045(08)70175-X. Review.

PMID:
18598933
[PubMed - indexed for MEDLINE]
19.

The cancer burden in Africa.

Vorobiof DA, Abratt R.

S Afr Med J. 2007 Oct;97(10):937, 939. No abstract available.

PMID:
18000571
[PubMed - indexed for MEDLINE]
Free Article
20.

Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer.

Abratt RP, Lee JS, Han JY, Tsai CM, Boyer M, Mok T, Kim SW, Lee JS, Brnabic AJ, Reece WH, Lehnert M.

J Thorac Oncol. 2006 Feb;1(2):135-40.

PMID:
17409842
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk